Towards Developing A Non‐SnCl2 Formulation for RP444, A New Radiopharmaceutical for Thrombus Imaging
There are many factors influencing the yield and radiochemical purity (RCP) of the radiopharmaceutical RP444. These include heating temperature, heating time, pH, the use of a buffering agent and a bulking agent, as well as the component (XV066, tricine, TPPTS, and Na99mTcO4) concentration. Through...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 2001-02, Vol.90 (2), p.114-123 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!